Risk of Subarachnoid Hemorrhage and Early Case Fatality Associated With Outpatient Antithrombotic Drug Use

Subarachnoid hemorrhage (SAH) accounts for 70 years (OR, 2.3; 95% CI, 1.8-3.1) and arterial hypertension (OR, 1.3; 95% CI, 1.0-1.6), but not with any of the antithrombotic drugs. Outpatient antithrombotic drug use was associated with an increased risk of SAH, but no association was observed with ear...

Full description

Saved in:
Bibliographic Details
Published in:Stroke (1970) 2013-09, Vol.44 (9), p.2422-2426
Main Authors: GARBE, Edeltraut, KREISEL, Stefan H, BEHR, Sigrid
Format: Article
Language:English
Subjects:
Adult
Aged
Anticoagulants - adverse effects
Biological and medical sciences
Case-Control Studies
Cohort Studies
Drug toxicity and drugs side effects treatment
Female
Germany - epidemiology
Humans
Male
Medical sciences
Middle Aged
Neurology
Pharmacology. Drug treatments
Platelet Aggregation Inhibitors - adverse effects
Registries - statistics & numerical data
Risk Factors
Sex Factors
Subarachnoid Hemorrhage - epidemiology
Subarachnoid Hemorrhage - etiology
Subarachnoid Hemorrhage - mortality
Toxicity: nervous system and muscle
Vascular diseases and vascular malformations of the nervous system
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Subarachnoid hemorrhage (SAH) accounts for 70 years (OR, 2.3; 95% CI, 1.8-3.1) and arterial hypertension (OR, 1.3; 95% CI, 1.0-1.6), but not with any of the antithrombotic drugs. Outpatient antithrombotic drug use was associated with an increased risk of SAH, but no association was observed with early case fatality.
ISSN:0039-2499
1524-4628
DOI:10.1161/STROKEAHA.111.000811